Kodiak Sciences Inc (NASDAQ: KOD) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KODIAK SCIENCES INC

Kodiak Sciences Inc (NASDAQ: KOD)
Listen to this Section


$5.83
+0.0600 ( +0.34% ) 199.7K

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Market Data


Open $5.83
Previous Close $5.77
Volume 199.7K
Market Cap $300.22M
Day Range $5.60 - $6.43
52 Week Range $2.19 - $11.60
Shares Outstanding 52.62M
Change % +0.34%
Net Change ▲ 0.0600
Insider Ownership -0.07%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Biological Products (No Diagnostic Substances)
IPO Year 2018
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -989,019.00

Date Type Amount Purchased Purchaser
2024-08-07 Sale -334500.00 BORGESON JOHN A.
2024-08-07 Sale -406000.00 PERLROTH VICTOR
2024-07-02 Sale -40000.00 BAKER BROS. ADVISORS LP
2024-07-01 Sale -40000.00 Bancroft Charles A
2024-07-01 Sale -40000.00 Dahiyat Bassil I
2024-07-01 Sale -40000.00 PROFUSEK ROBERT
2024-07-01 Sale -40000.00 Yang Taiyin
2024-07-01 Sale -40000.00 Levy Richard S
2024-06-18 Sale -5494.00 BORGESON JOHN A.
2024-06-13 Sale -3025.00 BORGESON JOHN A.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 42 Nov 14, 2024
8-k 8K-related 12 Nov 14, 2024
8-k 8K-related 12 Aug 14, 2024
10-q Quarterly Reports 40 Aug 14, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024

Latest News


× Before browsing our site, please accept our cookies policy